Several new studies feature developments in remyelination in MS. Oligodendrocyte precursor cells may be a promising target for MS treatments, and microRNA expression are perhaps an attractive MS biomarker.
Are you a US-based MD who sees patients with neurologic disorders and who likes to write? Why not blog for NeurologyTimes.com? It's your place to be heard on topics that keep you up at night. Contact us here and we can send you the details.